Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Becton, Dickinson and Company (BDX)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
263.69+4.29 (+1.65%)
At close: 04:00PM EDT
263.69 0.00 (0.00%)
After hours: 04:30PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • C
    Charles
    Great earnings and future. New growth to include cyto testing which will be big…
  • H
    Howie
    Maybe grows 10% a year and the PE is over 30? Stock needs to drop under 210.
  • B
    BORED#V+MUSK
    2 upgrades 305 PRICE TARGET AND 275 PRICE TARGET. You want own a stock you wont to worry about over the next 18 months. BD with a 4 dollar divy. and 20 to 25 percent upside. NO TO LATE FOLKS AT 241 (glta) HODL lol
  • B
    BORED#V+MUSK
    Earnings should show double digits growth easy. Next qtr will be the real winner so load up here before 275 break out. With 6 new products reflecting in q2 and q3 we finally have a catalyst for a much higher stock price. Please don't forget we should all be getting some of the diabetes spin off this year as well. Could not be more bullish for 2nd half of the year numbers. Once we get to 2022 we should trading somewhere between 325 to 350 putting in multiple quarters of substantial growth. For this who are holding and have been getting impatient. It's all going to be worth it next 12 months.
    Bullish
  • M
    M
    I have held this stock for quite a while. It’s has not appreciated much since I added it to my portfolio. But I know from past history whenever I sell the stick goes up. Also whenever I buy the stock goes down.
  • V
    Value Speculator
    If their Coronavirus virus test for present and past virus is real and can be mass market produced quickly, it will be a game changer.
  • E
    EandC
    I seriously think BD should stop being a Covid testing business. So far, they have been having a lot of challenges in that department. Besides, there are plenty of companies out there who have better tests. Although Covid tests are a very small portion of BD’s revenue (and profitability), any bad news regarding its Covid tests results in a tenfold negative impact on its shares. I think BD should just focus on its legacy business/products, and any Covid windfall (and its only temporary anyway!) will come from its vaccine delivery products. Stock price down $8/9 because some of its tests are having false readings? Well, even if BD loses all its revenue from the testing equipment, the bottom line will not change much. As for its other legacy business, we know it will come back in the next year. So I think this is a really good price point to get in – again, this is not a short term play; if you can hold on to this stock for 6 months and beyond, I am pretty confident it will go back to the $260 - $270 range within a year.
  • T
    Timothy
    Is there a pattern with this stock? Hits its high just before earnings and then big sell off post earnings release? Repeat …
  • D
    Darth
    What a great acquisition for BDX, they will make AKER a profitable company !
  • N
    NetDoggyDog
    Why does BDX not acquire or "lease" newer syringe technology from Retractable Technologies (RVP)? What is the litigation history between these two syringe producers? For half the $1.2B BDX is investing in their worldwide production, they could take out RVP. What am I missing?
  • K
    Kenny
    Will the price bounce back to $250 today?
    There been no bad news to be found.
  • B
    BORED#V+MUSK
    watch for the blow-out QTR here it comes. BDX made a 52 week in the midst of the correction. Inst are lining up. 300 this year Easy money. with 2percent kicker. GOBDX
  • M
    Michael
    This stock needs to split to attract more millennial investors.
  • C
    Charles
    Good earnings report, trading below lower Bollinger band, going ex dividend in less than a month.

    I kind of want to go all-in tomorrow morning.
    Bullish
  • G
    GammaRayStunks
    Wowowow. Guidance was the real deal. no more being range bound, will break out. The hedgies have been like clock work in and out 220 to 250. Was easy for them. A close over 270 and some upgrades I think we could easily see 320 to 350 this year. And we getting a nice little Divy. Cant beat it. This stock not going to get pounded down anymore. The wearable injectable they own the space. Next two years of syringes being in short supply. Its almost to easy. Diabetic market to expand 20% to 30% next 5 years.
  • A
    Anonymous
    BDX product demand will increase even more as hospitals open up for other non-virus health care items.
  • J
    Jamie
    Can someone tell me why BDX is going down in price, is it because of high operating expenses, in other words why are people selling, lost $15.00 in three days, April 17, 2018
  • R
    Ricardo
    FDA warning regarding probable long term mortality caution on Bards coated balloons.
  • B
    BORED#V+MUSK
    Another blow-out qtr. this is by far my favorite stock. Its my 2nd biggest holding behind MSFT and UNH. Look at your portfolio and this the one the will make 52 week and all new highs in this market. If you wish you owned Hersey the best performing stock in volatile mrkts buy BDX will be the same type of chart over the next 10 years.
    Granted the valuation is a bit rich however the growth will keep up with expectations for years to come. Don't be surprised to see more upgrades based on the qtr. good luck to all.
Advertisement
Advertisement